Antimicrobial Resistance Pattern of Mycobacterium Tuberculosis Complex Isolated from Extrapulmonary Tuberculosis Patientsin Sohag Governorate | ||||
| Sohag Medical Journal | ||||
| Article 7, Volume 22, Issue 3, October 2018, Page 51-61 PDF (129.98 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/smj.2018.31235 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Mostafa El-Mishad1; Abeer Mohamed1; Tamer Mahmoud1; Ekram Mahmoud2 | ||||
| 1Department of Medical Microbiology & Immunology, Faculty of Medicine, Sohag University. | ||||
| 2Department of Medical Microbiology & Immunology, Faculty of Medicine, Sohag University. | ||||
| Abstract | ||||
| As the number of drug resistant pulmonary TB is increasing around the world, the number of drug resistant TB with extrapulmonary manifestations are also on rise. However, there is surprisingly scant information in medical literatures on prevalence and impact of extrapulmonary drug-resistant TB Aim:This study aimed to detect and isolate Mycobacterium Tuberculosis Complex (MTC or MTBC) strains from extrapulmonary samples then determine the drug resistance pattern of these strains to antituberculus drugs. Materials and Methods: A total of 100 clinical specimens were collected during the study period from September 2016 to January 2018 at Medial Microbiology & Immunology Department, Sohag Faculty of Medicine from patients suspected to have EPTB. All samples subjected to ZN staining &cultures on LJ media then all positive culture were subjected for identification of the type of mycobacteria by two methods, phenotypically by biochemical tests and genotypically by conventional PCR fordetection of MTC.Antimicrobial susceptibility pattern was done for MTC strains. Results:Out of100 collected extrapulmonary samples, 66 samples were positive for mycobacterial culture. By using biochemical tests and PCR for identification of species, 53 isolates were identified as MTC and 13 isolates were identified as NTM. Antimicrobial susceptibility pattern was done for MTCstrains and detected 5 strains were MDR and one strain was XDR. Conclusion:Extrapulmonary TB infection rate in Sohag governorate is high and the problem of drug resistance in extrapulmonary tuberculosis (EPTB) cannot be overlooked. | ||||
|
Supplementary Files
|
||||
| References | ||||
|
1- Aderaye, G., Aseffa, A., Worku, A., & Lindquist, L. (2007).Comparison of acid-fast stain and culture for Mycobacterium tuberculosis in pre-and post-bronchoscopy sputum and bronchoalveolar lavage in HIV-infected patients with atypical chest X-ray in Ethiopia. Annals of thoracic medicine, 2(4), 154-157.
2- Arora, V. K., & Gupta, R. (2006). Trends of extra-pulmonary tuberculosis under revised national tuberculosis control programme: A study from South Delhi. Indian Journal of Tuberculosis, 53(2), 77.
3- Balaji, V., Daley, P., Anand, A. A., Sudarsanam, T., Michael, J. S., Sahni, R. D., ...& John, K. R. (2010).Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PloS one, 5(3), e9527.
4- Banerjee, R., Allen, J., Westenhouse, J., Oh, P., Elms, W., Desmond, E., ...& Flood, J. (2008).Extensively drug-resistant tuberculosis in California, 1993–2006. Clinical Infectious Diseases, 47(4), 450-457.
5- Cegielski, P., Nunn, P., Kurbatova, E. V., Weyer, K., Dalton, T. L., Wares, D. F., ...&Raviglione, M. (2012).Challenges and controversies in defining totally drug-resistant tuberculosis. Emerging infectious diseases, 18(11), e2.
6- Chakrabarti, A., Sharma, M., &Dubey, M. L. (1990). Isolation rates of different mycobacterial species from Chandigarh (north India). The Indian journal of medical research, 91, 111-114.
7- 7- Das, B. K., Sharma, V. K., Bhau, L. N., Saxena, S. N., &Bhardwaj, B. K. (1982).Characterisation of mycobacterial strains from clinical specimens. Indian journal of pathology & microbiology, 25(1), 19.
8- Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., ...&Theron, G. (2017).The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The lancet Respiratory medicine, 5(4), 291-360.
9- El-Dawi, T. G., Saeed, N. S. E. N., & Hamid, M. E. (2004).Evaluation of a PCR-amplified IS6110 insertion element in the rapid diagnosis of pulmonary tuberculosis in comparison to microscopic methods in Sudan. Saudi medical journal, 25(11), 1644-1647.
10-Forssbohm, M., Zwahlen, M., Loddenkemper, R., &Rieder, H. L. (2007).Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. European respiratory journal, 31:99–105.
11- Githui, W., Kitui, F., Juma, E. S., Obwana, D. O., Mwai, J., &Kwamanga, D. (1993).A comparative study on the reliability of the fluorescence microscopy and Ziehl-Neelsen method in the diagnosis of pulmonary tuberculosis. East African medical journal, 70(5), 263-266.
12- González, S. M., Cortés, A. C., Yoldi, L. A. S., García, J. M. G., Álvarez, L. M. A., & Gutiérrez, J. J. P. (2017). Micobacterias no tuberculosas.¿ Unaamenazaemergente?. Archivos de Bronconeumología, 53(10), 554-560.
13- Gupta, S., Goyal, R. K., Bareja, R., &Behara, R. N. (2016).Evaluation of various culture and staining techniques for the detection of extra pulmonary tuberculosis. International Journal of Research in Medical Sciences, 4(9), 3982-3987.
14- Gupta, S., Goyal, R. K., Bareja, R., &Behara, R. N. (2016).Evaluation of various culture and staining techniques for the detection of extra pulmonary tuberculosis. International Journal of Research in Medical Sciences, 4(9), 3982-3987.
15- Gurung, R., Bhattacharya, S. K., Pradhan, B., Gurung, S., & Singh, Y. I. (2010). Phenotypic characterisation and drug sensitivity testing of mycobacteria isolated from extra-pulmonary tuberculosis. Kathmandu University Medical Journal, 8(1), 57-61.
16- Henkle, E., Hedberg, K., Schafer, S. D., & Winthrop, K. L. (2017).Surveillance of ExtrapulmonaryNontuberculous Mycobacteria Infections, Oregon, USA, 2007–2012. Emerging infectious diseases, 23(10), 1627.
17- Hibah, N. A. A. (2015).Extrapulmonary tuberculosis situation in El-Behira Governorate, Egypt. Egyptian Journal of Bronchology, 9(1), 96–100.
18- Jain, A., Bhargava, A., &Agarwal, S. K. (2002). A comparative study of two commonly used staining techniques for acid fast bacilli in clinical specimens. Indian Journal of Tuberculosis, 49(3), 161-162.
19- Kohli, A., Bashir, G., Fatima, A., Jan, A., & Ahmad, J. (2016). Rapid drug-susceptibility testing of Mycobacterium tuberculosis clinical isolates to first-line antitubercular drugs by nitrate reductase assay: A comparison with proportion method. International journal of mycobacteriology, 5(4), 469-474.
20- Kumari, R., Sinha, P., Banerjee, T., &Anupurba, S. (2016).Isolation and characterization of Mycobacterium tuberculosis from extra pulmonary specimens in a tertiary referral hospital of north India. Journal of Advances in Medicine, 5(2), 25-28. 21- Lombardi, G., Di Gregori, V., Girometti, N., Tadolini, M., Bisognin, F., & Dal Monte, P. (2017). Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF. PloS one, 12(4), e0176186.
22- Maurya, A. K., Nag, V. L., Kant, S., Kushwaha, R. A. S., Kumar, M., Singh, A. K., & Dhole, T. N. (2015). Prevalence of nontuberculous mycobacteria among extrapulmonary tuberculosis cases in tertiary care centers in Northern India. BioMed research international, 2015.
23- Mohammadien, H., Alkhayat, K., Hamed, A., &Shaaban, M. (2017).Patterns, trends and treatment outcomes of extra-pulmonary tuberculosis in Sohag, Upper Egypt. Egyptian Journal of Chest Diseases and Tuberculosis, 66(2), 313-316.
24- Murray, S. J., Barrett, A., Magee, J. G., & Freeman, R. (2003).Optimisation of acid fast smears for the direct detection of mycobacteria in clinical samples. Journal of Clinical Pathology, 56(8), 613-615.
25- Nair, D., Capoor, M. R., Rawat, D., Srivastava, L., &Aggarwal, P. (2009). Standardization of first and second-line antitubercular susceptibility testing using BacT Alert 3D system: a report from a tertiary care centre in India. Brazilian Journal of Infectious Diseases, 13(6), 422-426.
26- Negi, S. S., Khan, S. F., Gupta, S., Pasha, S. T., Khare, S., &Lal, S. (2005). Comparison of the conventional diagnostic modalities, bactec culture and polymerase chain reaction test for diagnosis of tuberculosis. Indian journal of medical microbiology, 23(1), 29.
27- Nene, A., Kewalramani, N., &Agarwal, V. (2016). Prospective study analysing prevalence of XDR TB in Mumbai, India.
28- Noertjojo, K., Tam, C., Chan, S., & Chan-Yeung, M. M. (2002).Extra-pulmonary and pulmonary tuberculosis in Hong Kong. The International Journal of Tuberculosis and Lung Disease, 6(10), 879-886.
29- Peto, H. M., Pratt, R. H., Harrington, T. A., LoBue, P. A., & Armstrong, L. R. (2009).Epidemiology of extrapulmonary tuberculosis in the United States, 1993–2006. Clinical Infectious Diseases, 49(9), 1350-1357.
30- Pollett, S., Banner, P., O’Sullivan, M. V., & Ralph, A. P. (2016). Epidemiology, diagnosis and management of extra-pulmonary tuberculosis in a low-prevalence country: a four year retrospective study in an Australian Tertiary Infectious Diseases Unit. PloS one, 11(3), e0149372.
31- Pollett, S., Banner, P., O’Sullivan, M. V., & Ralph, A. P. (2016). Epidemiology, diagnosis and management of extra-pulmonary tuberculosis in a low-prevalence country: a four year retrospective study in an Australian Tertiary Infectious Diseases Unit. PloS one, 11(3), e0149372.
32- Pollett, S., Banner, P., O’Sullivan, M. V., & Ralph, A. P. (2016). Epidemiology, diagnosis and management of extra-pulmonary tuberculosis in a low-prevalence country: a four year retrospective study in an Australian Tertiary Infectious Diseases Unit. PloS one, 11(3), e0149372.
33- Pooja S., Surya K., Priyanka G., Abhilasha T., Sarika P.( 2018):Extra Pulmonary Tuberculosis: An Overview and Review of Literature, Int. J. Life. Sci. Scienti. Res, January 2018.
34- Prasanthi, K., &Kumari, A. R. (2005).Efficacy of fluorochrome stain in the diagnosis of pulmonary tuberculosis co-infected with HIV. Indian Journal of Medical Microbiology, 23(3), 179.
45-Qian, X., Nguyen, D. T., Lyu, J., Albers, A. E., Bi, X., &Graviss, E. A. (2018).Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis. Emerging microbes & infections, 7(1), 102.
35- Ranjan, K. P., & Sharma, M. (2010).An approach to the detection of mycobacteria in clinically suspected cases of urinary tract infection in immunocompromised patients.
36- Sachdeva, R., Gadre, D. V., &Talwar, V. (2002).Characterisation& drug susceptibility patterns of extrapulmonary mycobacterial isolates. Indian Journal of Medical Research, 115, 102.
37- Sadeghian,A., Tavakkol A., Ghanaat J., Sadeghain H., Namaii M. and Khodadoost M.(2005). Comparison of Three Methods for the Identification of Mycobacterium tuberculosis, INTERNATIONAL JOURNAL OF AGRICULTURE & BIOLOGY1560–8530/07–2–203–206
38- Sharma, S. K., Chaubey, J., Singh, B. K., Sharma, R., & Mittal, A. (2017). Drug Resistance Pattern AmongExtrapulmonary Tuberculosis Cases In A Tertiary Care Center In India. In A61. TUBERCULOSIS DISEASE: HOST RESPONSE AND DIAGNOSTICS (pp. A2086-A2086). American Thoracic Society.
39- Shinnick T, Jonas V (1994). Molecular approaches to diagnosis of tuberculosis. In: Bloom BR, editors. Tuberculosis. Pathogenesis, Protection and Control, ASM Press, Washington (DC), 517-530.
40- Singh, P. K., & Jain, A. (2015).Epidemiological perspective of drug resistant extrapulmonary tuberculosis. World J Clin Infect Dis, 5(4), 77-85.
41- Sobh, E., Kinawy, S. A. E., Abdelkarim, Y. M. A., &Arafa, M. A. (2016).The pattern of tuberculosis in Aswan Chest Hospital, Egypt. International journal of mycobacteriology, 5(3), 333-340.
42- Ulukanligil, M., Aslan, G., &Tasçi, S. (2000).A comparative study on the different staining methods and number of specimens for the detection of acid fast bacilli. Memorias do InstitutoOswaldo Cruz, 95(6), 855-858.
44- Umrao, J., Singh, D., Zia, A., Saxena, S., Sarsaiya, S., Singh, S., ...& Dhole, T. N. (2016). Prevalence and species spectrum of both pulmonary and extrapulmonarynontuberculous mycobacteria isolates at a tertiary care center. International journal of mycobacteriology, 5(3), 288-293.
45- Van B. K., Mirjam D., Tridiav.L., Kristin K., and Dick van Soolingen. (2007). Drug Susceptibility Testing of Mycobacterium tuberculosis Complex by Use of a High-Throughput, Reproducible, Absolute Concentration Method, JOURNAL OF CLINICAL MICROBIOLOGY, Vol. 45, No. 8, p. 2662–2668.
46- Yang, Z., Kong, Y., Wilson, F., Foxman, B., Fowler, A. H., Marrs, C. F., ...& Bates, J. H. (2004).Identification of risk factors for extrapulmonary tuberculosis. Clinical infectious diseases, 38(2), 199-205. | ||||
|
Statistics Article View: 224 PDF Download: 260 |
||||
